Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

CAFTECH

Financiado

Cerrado

Unraveling the therapeutic potential of cancer associated fibroblasts CAF in c...

Unraveling the therapeutic potential of cancer associated fibroblasts CAF in cancer using cell specific targeting technology Cancer is a major health burden affecting 12-million people each year world-wide. Tumor growth is not only determined by tumor cell malignancy but also by the tumor microenvironment. Cancer-associated fibroblasts (CAF) are key cel... ver más

31/07/2013

50K€

Presupuesto del proyecto: 50K€

Líder del proyecto

KAROLINSKA INSTITUTET No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2013-07-31 No tenemos la información de la convocatoria

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

0.00€ | Lider

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

STROMAMECH Targeting stromal cells to modify tumor mechanical microenvi... 152K€ Cerrado

MetCAF Uncovering the Role of Cancer Associated Fibroblasts in Faci... 1M€ Cerrado

DIN2018-009712 Desarrollo y validación de moléculas farmacológicas con capa... 65K€ Cerrado

3DTUMOUR Development of a high throughput microplate based device to... 150K€ Cerrado

PLEC2021-008106 Una nueva plataforma basada en micrometastasis-on-chip deriv... 638K€ Cerrado

DeShield Hide and Seek with Cancer Drugs 150K€ Cerrado

Líder del proyecto

KAROLINSKA INSTITUTET No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 50K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Cancer is a major health burden affecting 12-million people each year world-wide. Tumor growth is not only determined by tumor cell malignancy but also by the tumor microenvironment. Cancer-associated fibroblasts (CAF) are key cell type in the tumor microenvironment influencing tumor initiation, angiogenesis, metastasis and tumor drug response. CAF strongly express platelet-derived growth factor receptors (PDGFR). The applicant has recently developed a novel drug delivery technology to target CAF using a PDGFR-binding carrier (HPC) which is composed of a PDGFR-binding cyclic peptide conjugated to albumin. Targeting of doxorubicin using HPC induced anticancer effects by depleting tumor stromal tissue in-vivo. This proposal aims to further exploit this technology to investigate the therapeutic potential of CAF in tumor. In the first part of the project, we will study the impact of CAF on tumor initiation, metastasis and tumor drug uptake. To carry out this, we will use doxo-HPC in order to kill CAF selectively in tumors and examine the effect on latter parameters. Of note, these experiments will be performed in the state-of-the-art genetically-modified tumor models specifically developed to study these tumor mechanisms. In the second part, we will study the relative importance of different signaling pathways (PDGF, TGF-beta and hedgehog) in CAF. Different inhibitors of these pathways will be conjugated to HPC. Treatment with these conjugates will induce blockade of these pathways in CAF through which we can study their importance in CAF-inducing effects. This project thus brings together the expertise of the applicant in targeted drug delivery with the experimental therapy expertise of the host group. Surely, this project will help the researcher in long-term integration and to explore his knowledge and skills to develop novel anti-CAF therapies. The project will also yield new scientific excellence with the potential of benefiting human health and European economy.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores